CITF-funded findings on seroprevalence and effects of COVID-19 on children and adolescents

Ongoing monitoring of the serological status of children is important, particularly in the context of new variants of concern, low vaccine coverage, and low uptake of testing. Here, members of the CITF Secretariat summarize results from the four presentations given during the breakout session, “Seroprevalence and effects of COVID-19 on children and adolescents,” at the CITF Scientific Meeting in Vancouver, March 8-10, 2023.

2023-08-21T12:06:08-04:00August 21, 2023|Pediatrics|

Respiratory syncytial virus antibody functions diminished during peak of COVID-19 pandemic, causing more severe RSV infections

A CITF-funded study, published in preprint and not-yet peer-reviewed, found that the almost complete absence of RSV circulation during the peak of COVID-19 pandemic mitigation measures led to waning antibody-mediated and cellular responses that protect against severe respiratory syncytial virus (RSV) infection.

2023-08-21T11:59:35-04:00August 21, 2023|Pediatrics|

Kids’ time spent on screens and outdoor activity affected by lockdown stages of the COVID-19 pandemic

A CITF-funded study, published in the Journal of Physical Activity and Health, found that children under 5 years of age had greater increases in screen use, but lower increases in physical activity and outdoor play time compared to children between the ages of 5 and 12 during COVID-19 lockdowns. This study was led by Dr. Jonathan Maguire (University of Toronto).

2023-03-21T11:16:20-04:00March 20, 2023|Pediatrics|

Vaccine hesitancy among parents of children and teens 5-18 years old

A CITF-funded study published in the Canadian Medical Association Journal (CMAJ) discussed how parents’ experiences making decisions regarding SARS-CoV-2 vaccines for their children were complex, even for those who were supportive of vaccination. The study was led by Drs. Jonathan Maguire and Janet Parsons (University of Toronto). This research is part of the TARGet Kids! (Applied Research Group for Kids) Study.

2023-02-28T12:04:46-05:00February 28, 2023|Pediatrics|

Timely surveillance of respiratory syncytial virus (RSV) cases in children showed recent increased circulation

In a preprint, not yet peer-reviewed, CITF-funded researcher Dr. Pascal Lavoie (University of British Columbia) and colleagues found that children in British Columbia have been more vulnerable to respiratory syncytial virus (RSV) following a lull while protective measures were in place at the height of the COVID-19 pandemic.

2022-11-28T16:45:07-05:00November 28, 2022|Pediatrics|

Risk factors for SARS-CoV-2 seropositivity and seroconversion among children and adolescents in Montreal

In a preprint, not yet peer-reviewed, CITF-funded researchers Drs. Kate Zinszer (University of Montreal) and Caroline Quach (University of Montreal, Research Centre of the Sainte-Justine University Hospital) identified a variety of factors that contributed to an increased risk of seropositivity and seroconversion in children and adolescents.

2022-11-08T09:32:19-05:00November 7, 2022|Pediatrics|

The methodology of the CHILD sub-study to examine the effect of SARS-CoV-2 infection on children

In a pre-print, not yet peer reviewed, Dr. Meghan Azad (University of Manitoba) and her team reported on the study design and cohort profile for research examining the prevalence and predictors of SARS-CoV-2 infection and transmission, as well as the predictors of the health and psychosocial impacts from the COVID-19 pandemic among Canadian children and their families.

2022-10-31T15:02:33-04:00October 31, 2022|Pediatrics|
Go to Top